![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Wierzbicki A.S.
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.1, Iss.5, 2001-01, pp. : 327-336
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Llaverias Gemma Pou Jordi Ros Emilio Zambóón Daniel Cofáán Montserrat Sáánchez Alex Váázquez-Carrera Manuel Sáánchez Rosa M Laguna Juan C Alegret Marta
Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Multiple Lipid-lowering Treatment in Pediatric Patients with Hyperlipidemia
Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Should Pediatric Patients with Hyperlipidemia Receive Drug Therapy?
By Bhatnagar D.
Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Kiortsis D.N. Millionis H. Bairaktari E. Elisaf M.S.
European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. :